SecBot SecBot
Insider Cluster (2 insiders) ·Filed Aug 7, 2026

BRVE

Braveheart Bio, Inc.
BULLISH
Impact 7/10
Horizonweeks Processed2mo ago
Insider cluster: 2 insiders, $1.5M total
Actionable Insight ▲ Bullish

The CFO and a director both buying aggressively at the same price point is a rare and powerful alignment signal. Traders should watch for an upcoming catalyst (earnings, pipeline update, or partnership) within the next 2-4 weeks. The non-cash grants on 8/5 suggest a compensation event, but the open-market purchases on 8/7 are the real signal — these are discretionary, not plan-driven.

DirectionBullish
Confidencehigh
Horizonweeks
Latest settled — T+20d ⚠ clustered
BRVE ▲ +6.83% at T+20d
LONG call ✓ call won +6.83% · α vs SPY +7.74% · entry $27.53 → $29.41
Next anchor: T+60d in 6d
Entry = T+0 close
Aug 7, 2026
via day close
T+1d
-9.15%
call -9.15% · α -8.83%
$25.01
settled 3mo ago
T+5d
+0.47%
call +0.47% · α +0.52%
$27.66
settled 2mo ago
T+20d
+6.83%
call +6.83% · α +7.74%
$29.41
settled 8w ago
T+60d
Pending
in 6d

Price Chart

Loading chart...

Executive Summary

Two insiders at Braveheart Bio, including the CFO and a director, made open-market purchases totaling $1.5M at $18/share over two days. This cluster of insider buying, particularly the CFO's participation, is a strong bullish signal that typically precedes positive company developments or undervaluation recognition.

Key Financial Metrics

Direction
buying
Total Value
$1.5M
Insiders
2

Key Facts

  • CFO Rickey James Paul purchased 27,777 shares for ~$500K on 2026-08-07
  • Director Lubner David Charles purchased 55,555 shares for ~$1M on 2026-08-07
  • Both insiders also received non-cash grants/awards of 300K and 60K shares respectively on 2026-08-05
  • Total open-market purchase value is $1.5M, representing a significant insider vote of confidence
  • No 10b5-1 plan or regular pattern detected — these appear to be conviction buys

Financial Impact

Insiders deployed $1.5M of personal capital at $18/share, a material amount for a company of this size

insider ownershipmarket sentiment

Risk Factors

  • Insider buying does not guarantee short-term price appreciation; catalysts may take months to materialize
  • The company's market cap is not provided, so proportionality to market cap cannot be fully assessed, but $1.5M is material in absolute terms for a small-cap biotech

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-BRVE-1786169038720
8 reports for BRVE
Performance horizon
60% Hit rate @ T+20 3 of 5 directional calls Went positive at some point 5 of 5 best @ T+5▲ +10.78%Aug 11, 2026
Filters
Rows
Reports for BRVE — sortable, filterable
TypeNow
Aug 14, 2026
10w ago
3
NEUTRAL ★ 2/10
$27.66 $26.71▼ −3.43%▼ −1.46%$21.82 (−21.11%)
Aug 11, 2026
10w ago
Insider Cluster
BULLISH ★ 8/10
$26.15 $27.25▲ +4.21%▲ +6.10%$21.82 (−16.56%)
Aug 11, 2026
11w ago
Insider Cluster
BULLISH ★ 8/10
$26.15 $27.25▲ +4.21%▲ +6.10%$21.82 (−16.56%)
Aug 7, 2026
11w ago
Insider Cluster
BULLISH ★ 7/10
$27.53 $29.41▲ +6.83%▲ +7.74%$21.82 (−20.74%)
Aug 7, 2026
11w ago
Insider Cluster
BULLISH ★ 7/10
$27.53 $29.41▲ +6.83%▲ +7.74%$21.82 (−20.74%)
Aug 5, 2026
11w ago
Press Release
BULLISH ★ 7/10
$29.80 $26.27▼ −11.85%▼ −12.45%$21.82 (−26.78%)
Aug 5, 2026
11w ago
3
BULLISH ★ 7/10
$29.80 $26.27▼ −11.85%▼ −12.45%$21.82 (−26.78%)
Aug 5, 2026
11w ago
3
NEUTRAL ★ 3/10
$29.80 $26.27▼ −11.85%▼ −12.45%$21.82 (−26.78%)
Showing 8 of 8

US Market Status

Market Closed — Opens Wed (15h 40m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 8, 2026